PT  - JOURNAL ARTICLE
AU  - Summers, Jaye
ED  - Dellon, Evan
TI  - Budesonide Shows Validated Promise in Patients With Eosinophilic Esophagitis
DP  - 2015 Sep 07
TA  - MD Conference Express
PG  - 16--16
VI  - 15
IP  - 14
4099  - http://mdc.sagepub.com/content/15/14/16.short
4100  - http://mdc.sagepub.com/content/15/14/16.full
AB  - In a randomized placebo-controlled trial, adults and adolescents with active EoE both histologically and symptomatically were given either oral budesonide or placebo for 12 weeks. Using a validated symptom tool and biopsy data, the results suggest a significant improvement in both symptoms and histology among those in the budesonide group, with no impending safety signals.